16 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
, national origin, physical disability, or age, are empowered to achieve their full potential. The unique talents, backgrounds and perspectives of each … of the disability, death, termination or other cessation of employment or service, authorized leave of absence or other change in the employment or other
425
SYRS
Syros Pharmaceuticals Inc.
15 Sep 22
Business combination disclosure
4:08pm
and conditions in addition to those set forth in the Plan.
(c) Termination of Status. The Board shall determine the effect on an Award of the disability, death
8-K
EX-99.1
aw4icxvbzv3kt
15 Sep 22
Departure of Directors or Certain Officers
4:06pm
S-4
EX-10.5
xmkqjkofj9 mugqd3e
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
425
qby1lko1qpyp bn74odx
5 Jul 22
Business combination disclosure
7:14am
8-K
EX-2.1
yf7nm
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
8-K
EX-10.2
m04f9nfs1usuu6
13 Oct 21
Departure of Directors or Certain Officers
4:01pm
8-K
EX-2.1
8s38as7i54r45k
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-1.1
5u5cqr22
13 Feb 20
Syros Announces $60 Million Loan Facility with Oxford Finance LLC
8:51am
- Prev
- 1
- Next